Cowen & Co. analyst Yaron Werber maintained a Buy rating on Alector Inc (ALEC) today. The company’s shares opened today at $18.23.
According to TipRanks.com, Werber is a 4-star analyst with an average return of 11.9% and a 61.3% success rate. Werber covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Inc., Rocket Pharmaceuticals Inc, and Prevail Therapeutics Inc.
Alector Inc has an analyst consensus of Moderate Buy.
See today’s analyst top recommended stocks >>
The company has a one-year high of $27 and a one-year low of $15.16. Currently, Alector Inc has an average volume of 123.7K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer’s disease, and Parkinson’s disease.
